Three insights on psychoneuroimmunology of mood disorders to be taken from the COVID-19 pandemic

Elisa Brietzke; Taylor Magee; Rafael C R Freire; Fabiano A Gomes; Roumen Milev

doi:10.1016/j.bbih.2020.100076

Three insights on psychoneuroimmunology of mood disorders to be taken from the COVID-19 pandemic

Brain Behav Immun Health. 2020 May:5:100076. doi: 10.1016/j.bbih.2020.100076. Epub 2020 Apr 22.

Authors

Elisa Brietzke^{1

2

3}, Taylor Magee¹, Rafael C R Freire^{1

2

3

4}, Fabiano A Gomes^{1

2

3}, Roumen Milev^{1

3

4}

Affiliations

¹ Department of Psychiatry, Queen's University School of Medicine, Kingston, ON, Canada.
² Kingston Health Sciences Centre, Kingston, ON, Canada.
³ Centre for Neuroscience Studies (CNS), Queen's University, Kingston, ON, Canada.
⁴ Providence Care Hospital, Kingston, ON, Canada.

Abstract

In the recent months, the world was taken by surprise by the outbreak of a coronavirus (SARS-CoV-2) pandemic (COVID-19). The COVID-19 pandemic is a unique opportunity to advance the understanding of the association of respiratory viruses with mood disorders and suicide. In this editorial, we explore three insights to the neuropsychoneuroimmunology of mood disorders that could be taken from the COVID-19 pandemic.

Keywords: Aging; COVID-19; Coronavirus; Immunosenesce; Mood disorders; Suicide.

Publication types

Review